John Wesolowski - Perrigo Company Executive Vice President and Presidentident - RX

PRGO -- USA Stock  

USD 47.13  0.06  0.13%

  President
Mr. John Wesolowski is Executive Vice President, President RX of the Company. Mr. Wesolowski was named Executive Vice President, President RX in November 2016. He previously was named as Acting General Manager, RX, in July 2016 and served in that capacity until November 2016. Previously, he served as Senior Vice President of RX Commercial Operations, from 2013 until July 2016
Age: 49  President Since 2016      
353 1 709 4000  http://www.perrigo.com
Wesolowski joined Perrigo in February 2004 as the Vice President, RX Sales and Marketing and was subsequently promoted to the Senior Vice President of RX Sales and Marketing in 2012.

Management Efficiency

The company has return on total asset (ROA) of 2.34 % which means that it generated profit of $2.34 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 1.49 % meaning that it created $1.49 on every $100 dollars invested by stockholders.
The company currently holds 3.62B in liabilities with Debt to Equity (D/E) ratio of 63.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 1.88 which is within standard range for the sector.

Similar Executives

Showing few of many executives

PRESIDENT Since

J RamachandranDr Reddys Laboratories Ltd
2016
Reshma KewalramaniVertex Pharmaceuticals Incorpor
2018
Kimberly WhiteVertex Pharmaceuticals Incorpor
2018
Roxanne LaganoZoetis
2015
Raghav ChariDr Reddys Laboratories Ltd
2013
John GrayVertex Pharmaceuticals Incorpor
2019
Thomas GraneyVertex Pharmaceuticals Incorpor
2017
Stefan WeiskopfZoetis
2013
Paul SilvaVertex Pharmaceuticals Incorpor
2019
Joyce LeeZoetis
2012
Peter PowchikRegeneron Pharmaceuticals
2006
Clinton LewisZoetis
2018
K RaoDr Reddys Laboratories Ltd
2016
Daniel PlewRegeneron Pharmaceuticals
2016
Michael PariniVertex Pharmaceuticals Incorpor
2017
Umang VohraDr Reddys Laboratories Ltd
2013
Douglas McCorkleRegeneron Pharmaceuticals
2007
M RamanaDr Reddys Laboratories Ltd
2018
Marion McCourtRegeneron Pharmaceuticals
2018
Christopher FenimoreRegeneron Pharmaceuticals
2017
Ganadhish KamatDr Reddys Laboratories Ltd
2016

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Current Sentiment - PRGO

Perrigo Company Investor Sentiment

Most of Macroaxis users are at this time bullish on Perrigo Company plc. What is your perspective on investing in Perrigo Company plc? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

Z   
Purchased over 200 shares of
few hours ago
Traded for 36.01
BIDU   
Purchased over 90 shares of
few hours ago
Traded for 104.22
PANW   
Purchased over 20 shares of
few hours ago
Traded for 198.03
TCEHY   
Purchased over 200 shares of
few hours ago
Traded for 42.74
Additionally take a look at Your Equity Center. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Search macroaxis.com